- 英文名称
- 9-[2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl]-2,6-dichloropurine
- 分子式
- C16H16Cl2N4O7
- 分子量
- 447.23
- 中文别名
- 2,6-二氯-9-(2',3',5'-三-O-乙酰基-BD-呋喃核糖基)嘌呤; 2,6-二氯-9-(2,3,5-三-O-乙酰基-BETA-D-呋喃核糖基)-9H-嘌呤; 9-[2,3,5-三-O-乙酰-BETA-D-呋喃核糖基]-2,6-二氯嘌呤; 2,6-二氯嘌呤-2',3',5'-三乙酰; (2R,3R,4R,5R)-2-(乙酰氧基甲基)-5-(2,6-二氯-9H-嘌呤-9-基)四氢呋喃-3,4-二乙酸二酯; 2,6-二氯-2',3',5'-三乙酰基嘌呤核糖苷; 9-[2,3,5-三-O-乙酰基-β-D-呋喃核糖基]-2,6-二氯; [3,4-Bis(acetyloxy)-5-(2,6-dichloro-9H-purin-9-yl)oxolan-2-yl]methyl acetate; [(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2,6-dichloropurin-9-yl)oxolan-2-yl]methyl acetate; 2',3',5'-Tri-O-Acetyl-2,6-Dichloropurine; [3,4-BIS(ACETYLOXY)-5-(2,6-DICHLOROPURIN-9-YL)OXOLAN-2-YL]METHYL ACETATE; (2R,3R,4R,5R)-4-(acetyloxy)-2-[(acetyloxy)methyl]-5-(2,6-dichloro-9H-purin-9-yl)tetrahydro-3-furanyl acetate; 9H-Purine, 2,6-dichloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-; (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,6-dichloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate; 2,6-Dichloro-2',3',5'-triacetyl-purine riboside
- 用途
- 概述
2,3,5-三乙酰-2,6-二氯嘌呤核苷 是一种嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性，靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制 DNA 合成，诱导细胞凋亡 (apoptosis) 等。
